The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key territories has introduced considerable uncertainty . Investors are now facing the consequences of rival medicatio